Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
145
24
28
32
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.5%
8 terminated/withdrawn out of 145 trials
80.0%
-6.6% vs industry average
6%
9 trials in Phase 3/4
6%
2 of 32 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (145)
Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer
Role: lead
Comparative Evaluation of 68Ga-FAPI and 68Ga-DOTATATE PET/CT and PET/MRI in Thyroid Eye Disease
Role: lead
A Study of Tislelizumab Combined With TAC Regimen as Neoadjuvant Therapy for TNBC
Role: lead
Single-port Robotic Radical Gastrectomy for Gastric Cancer
Role: lead
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Role: lead
Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer
Role: lead
Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation
Role: collaborator
LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
Role: lead
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Role: lead
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
Role: lead
Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study
Role: lead
Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment
Role: lead
Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases
Role: lead
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors
Role: lead
Clinical Study of Trap-(FAPI)3 PET Imaging in the Diagnosis of Pulmonary Nodules
Role: lead
Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging
Role: lead
Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas
Role: lead
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Role: lead